Mostrar el registro sencillo del ítem
Autor | Cunha, Mariana G. A. Teixeira da | |
Autor | Gomes, Rachel N. | |
Autor | Roehrs, Nathassia | |
Autor | Bozza, Fernando A. | |
Autor | Prescott, Stephen M. | |
Autor | Stafforini, Diana | |
Autor | Zimmerman, Guy A. | |
Autor | Bozza, Patrícia T. | |
Autor | Faria Neto, Hugo C. Castro | |
Fecha de acceso | 2016-01-22T17:06:17Z | |
Fecha de disponibilización | 2016-01-22T17:06:17Z | |
Fecha de publicación | 2013 | |
Referencia | CUNHA, Mariana G. A. Teixeira da; Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration. Plos One, v.8, n.9, e74567. 7p, 2013. | pt_BR |
ISSN | 1932-6203 | |
URI | https://www.arca.fiocruz.br/handle/icict/12598 | |
Idioma | eng | pt_BR |
Editor | Public Library of Science | pt_BR |
Derechos de autor | open access | |
Título | Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration | pt_BR |
Tipo del documento | Article | |
DOI | 10.1371/journal.pone.0074567 | |
Resumen en Inglés | Current evidence indicates that dysregulation of the host inflammatory response to infectious agents is central to the mortality of patients with sepsis. Strategies to block inflammatory mediators such as PAF have been investigated as adjuvant therapies for sepsis. PAF-AH, the enzyme responsible for PAF degradation, showed positive results in pre-clinical studies and phase II clinical trials, but the results of a phase III study were disappointing. In this study, we investigated the potential protective mechanism of PAF-AH in sepsis using the murine model of cecal ligation and puncture (CLP). Treatment with rPAF-AH increased peritoneal fluid levels of the anti-inflammatory mediators MCP-1/CCL2 after CLP. The numbers of bacteria (CFU) in the peritoneal cavity were decreased in the rPAF-AH-treated group, indicating more efficient bacterial clearance after rPAF-AH treatment. Interestingly, we observed increased levels of nitric oxide (NO) after PAF-AH administration, and rPAF-AH treatment did not decrease CFU numbers either in iNOS-deficient mice or in CCR2-deficient mice. We concluded that administration of exogenous rPAF-AH reduced inflammatory injury, altered cytokine levels and favored bacterial clearance with a clear impact on mortality through modulation of MCP-1/CCL2 and NO levels in a clinically relevant sepsis model. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Laboratório de Investigação em Medicina Intensiva. Rio de Janeiro, RJ, Brasil. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Laboratório de Investigação em Medicina Intensiva. Rio de Janeiro, RJ, Brasil | pt_BR |
Afiliación | Oklahoma Medical Research Foundation. Oklahoma City, USA. | pt_BR |
Afiliación | Huntsman Cancer Institute. Salt Lake City, Utah, USA. | pt_BR |
Afiliación | University of Utah. Program in Human Molecular Biology and Genetics. Salt Lake City, Utah, USA. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Palavras clave en Inglês | Platelet-Activating Factor-Acetylhydrolase (PAF-AH) | pt_BR |
Palavras clave en Inglês | Sepsis | pt_BR |
DeCS | Sepse | pt_BR |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
INI - Artigos de Periódicos [3397]
-
IOC - Artigos de Periódicos [12500]